Card image cap
Antibiotics have successfully treated gonorrhea for several decades; however, the bacteria has developed resistance to nearly every drug used for treatment.*  

Over 800K new infections occur in the US annually. Many infected people don’t show symptoms; hence over 50% are not reported to CDC.

Little stands between US and untreatable Gonorrhea

  • Gonorrhea has progressively developed resistance to the antibiotic drugs commonly used to treat it complicate the ability of providers to treat gonorrhea 
  • It is critical to continuously test and monitor antibiotic resistance in Neisseria gonorrhoeae and encourage research and development of new treatment regimens.

Biomed Diagnostics supports the efforts of the CDC Gonococcal Surveillance Programs. 
Many participating health clinics in the GISP/SURRG programs have incorporated the Biomed InTray GC into their AMR testing and surveillance programs.




Card image cap
InTray GC for N. gonorrhoeae testing

“Four commercial transport systems for the recovery of Neisseria gonorrhoeae were evaluated in support of the need to obtain culture isolates for the detection of antimicrobial resistance.

Bacterial recovery from the InTray GC system was superior with minimal loss of viability in contrast to non-nutritive transport systems.” **

  • Save time and money, improve workflow and throughput,
  • Reduce sample exposure and contamination
  • Combine sample inoculation, incubation and detection in a single device
  • Eliminate the need for costly CO2 incubators. 
  • InTray GC allows for simultaneous detection and observation of Neisseria gonorrhoeae.

Product Principles:

  • Storage - Refrigeration (2-8°C)
  • Incubation - 24-48 hours at 37°C

Available Quantities:

  • 20 Pack
  • 5 Pack



Card image cap
CDC STD Awareness 2020

In support of our Customers and CDC STD Awareness 2020 Biomed is sharing critical information about two serious STD infections. Both are very prevalent, and the infections are becoming difficult to treat, due to the growth of anti-microbial resistance of the microbe. This means that time-tested treatments are no longer effective. New research and new treatment strategies are imperative

The study cited below highlights Trichomonas Vaginalis, a highly prevalent STD infection that affects women primarily, but also affects men. Trichomoniasis is a highly contagious, nonviral sexually transmitted Infection. There are approximately 270 million reported cases each year.

Trichomonas Vaginalis was featured as the Parasite of the Month by Cell Press Trends in Parasitology – to call attention to effective treatment. Despite decades of drug resistance being documented, there is still only one treatment option.

Trichomoniasis is associated with poor birth outcomes and increased risks of HIV transmission and cervical cancer. T. vaginalis-induced immunomodulation, contributes to pathology, HIV spread, and immune evasion.

Read the Parasitology Article here ►


Biomed Diagnostics is committed to overcoming Trichomonas vaginalis.

InPouch® TV is a cost-effective, easy to use, broth media device for combined collection, incubation, and detection. Biomed's Diagnostics' Gold Standard media for T. vaginalis within InPouch TV is formulated for specificity — inhibiting the growth of yeasts, molds, bacteria and other micro-flora.

Learn More ►




To request a quote please fill out your information below: